Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SOPH vs WORX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
WORX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 3–5 Matrix Metrics)
WORX Overall Winner
6-Pillar Tally: SOPH 2 – 4 WORX
Matrix Metrics: SOPH 5 – 3 WORX
As of Nov 16, 2026, SC WORX Corp (WORX) is the stronger overall head-to-head candidate over SOPHiA GENETICS SA (SOPH) in the Tradestie Institutional Equity Comparison Engine, winning 3–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SOPH carries a Unified Composite Score of 49.8/100 (HOLD) at $7.44 (N/M Forward P/E, -81.0% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin).
- Composite vs. Pillar Nuance: While SOPH currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. WORX 34.1/100 SELL), WORX captures the overall institutional head-to-head verdict (3–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-20.1% vs. -81.0% operating margin) and revenue trajectory (+3.4% vs. +24.7% YoY).
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About SOPH vs WORX
SOPH
SOPHiA GENETICS SA Ordinary Shares
$7.44
-9.38% 1D
Market Cap
$703.3M
TTM Revenue
$91M
Forward P/E
N/M
Beta / 30D Vol
1.28β · 78% Vol
Unified Composite Score
49.8
HOLD
Tech 23.0
Fund 48.0
Flow 60.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
WORX
Head-to-Head Winner
SC WORX Corp
$1.15
-6.5% 1D
Market Cap
$1.7M
TTM Revenue
$2.9M
Forward P/E
N/M
Beta / 30D Vol
23.01β · 208% Vol
Unified Composite Score
34.1
SELL
Tech 15.0
Fund 31.0
Flow 50.0
Mom 30.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (SOPH 2 – 4 WORX)
1. Valuation Multiples
WORX
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
7.4x
0.6x
2. Growth & Scale
SOPH
Revenue Growth (YoY)
+24.7%
+3.4%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$91M
$2.9M
Market Cap
$703.3M
$1.7M
3. Profitability & Quality
WORX
Gross Margin
66.4%
44.7%
Operating Margin
-81.0%
-20.1%
Net Profit Margin
-89.2%
-80.5%
Return on Equity (ROE)
-125.7%
-38.1%
4. Balance Sheet & Cash Flow
WORX
Cash Generation (TTM)
-$51M
-$914,262
Cash Flow Margin
-55.8%
-31.2%
Net Cash / Leverage
$33M Net Cash
$77.66 Book/Sh · -38.1% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
SOPH
Options Structure Phase
CONSOLIDATION
UNCLASSIFIED
Current IV / %ile
68.1% (38th %ile)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
ACCUMULATION · Neutral
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
WORX
OpEx & R&D Intensity
N/A
64.8% of Rev ($1.9M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Health Information Services Operator
Health Information Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: SOPH (5) vs WORX (3)| Institutional Metric | SOPH | WORX | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $703.3M | $1.7M | SOPH | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +24.7% | +3.4% | SOPH | |
| Operating Margin (TTM) | -81.0% | -20.1% | WORX | |
| Net Profit Margin | -89.2% | -80.5% | WORX | |
| Return on Equity (ROE) | -125.7% | -38.1% | WORX | |
| 52-Week Range Position | 70% ($4–$9) | 17% ($0–$6) | SOPH | |
| Beta / 30D Volatility | 1.28β · 78% Vol | 23.01β · 208% Vol | SOPH | |
| Unified Institutional Score | 49.8 / 100 (HOLD) | 34.1 / 100 (SELL) | SOPH | |
| Trailing 12M Revenue (USD) | $91M | $2.9M | Scale | |
| Gross Profit Margin (TTM) | 66.4% | 44.7% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 7.4x EV/Rev | N/M PEG · 0.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$51M ($33M Net Cash) | -$914,262 ($77.66 Book/Sh · -38.1% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
SOPH +27.22 pp
3M Horizon
WORX +166.64 pp
6M Horizon
WORX +241.81 pp
1Y Horizon
WORX +192.92 pp
Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | SOPH Revenue | WORX Revenue | SOPH Op. Margin | WORX Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| Q3 '25 | $80M | $0M | -91.8% | -19.7% | WORX |
| Q4 '25 | $90M | $0M | -85.3% | -25.0% | WORX |
| Q1 '26 | $90M | $0M | -79.7% | -18.2% | WORX |
| Q2 '26 | $90M | $0M | -86.0% | -17.1% | WORX |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
SOPH
CONSOLIDATION
Current IV
68.1%
IV Percentile
38th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact SOPH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
WORX
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact WORX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
SOPH Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
WORX Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
OpEx & R&D Reinvestment
64.8% of Rev ($1.9M)
90D Engineering Disclosures
0 Published
Investor FAQ SOPH vs WORX Key Questions & Quantitative Answers
As of Nov 16, 2026, SC WORX Corp (WORX) is the stronger overall head-to-head candidate over SOPHiA GENETICS SA (SOPH) in the Tradestie Institutional Equity Comparison Engine, winning 3–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SOPH carries a Unified Composite Score of 49.8/100 (HOLD) at $7.44 (N/M Forward P/E, -81.0% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin). Composite vs. Pillar Nuance: While SOPH currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. WORX 34.1/100 SELL), WORX captures the overall institutional head-to-head verdict (3–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-20.1% vs. -81.0% operating margin) and revenue trajectory (+3.4% vs. +24.7% YoY).
SOPH leads the Growth & Scale pillar: SOPH posts +24.7% YoY revenue growth and +0.0% YoY earnings growth on $91M TTM revenue (66.4% gross margin, -81.0% operating margin), compared with WORX at +3.4% YoY revenue growth and +0.0% YoY earnings growth on $2.9M TTM revenue (44.7% gross margin, -20.1% operating margin). Across the 4-period historical trajectory (Q3 '25 to Q2 '26), SOPH cumulative revenue shifted +12.5% while WORX shifted N/A. In operating R&D and SG&A reinvestment, SOPH deploys N/A (0 90-day corporate R&D disclosures) versus 64.8% of Rev ($1.9M) (0 disclosures) for WORX.
WORX screens cheaper on headline valuation multiples. SOPH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 7.4x EV/Revenue (-55.8% FCF margin), whereas WORX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-31.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SOPH (-125.7% ROE) versus WORX (-38.1% ROE) capital efficiency.
In options market volatility and institutional positioning, SOPH carries 68.1% implied volatility (38th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.28β · 78% Vol realized risk). By comparison, WORX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.01β · 208% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
WORX vs SOPH · Reverse Pair
SOPH vs RLYB
· Sector Peer
SOPH vs SGHT
· Sector Peer
SOPH vs TKNO
· Sector Peer
WORX vs SAIQ
· Sector Peer
WORX vs VEEA
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem